- Home
- DHF vs INFU Comparison
DHF vs INFU Comparison
Compare DHF & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DHF | INFU |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.2M | 197.0M |
| IPO Year | 1998 | 2005 |
Fundamental Metrics
Financial Performance| Metric | DHF | INFU |
|---|---|---|
| Price | $2.40 | $12.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 273.8K | 173.4K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | N/A | $3.20 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ N/A | $62.40 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $2.32 | $7.29 |
| 52 Week High | $2.63 | $12.97 |
Technical Indicators
Market Signals| Indicator | DHF | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 63.90 |
| Support Level | $2.38 | $8.40 |
| Resistance Level | $2.42 | $12.97 |
| Average True Range (ATR) | 0.03 | 0.71 |
| MACD | 0.01 | 0.19 |
| Stochastic Oscillator | 62.50 | 79.32 |
Price Performance
Historical ComparisonAbout DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. The fund invests predominantly in fixed-income securities of below-investment-grade credit quality.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.